Wednesday, January 12, 2011
Incontinence After Prostate Surgery May be Helped by Therapy (HealthDay)
(HealthDay): "HealthDay - TUESDAY, Jan. 11 (HealthDay News) -- Nearly two-thirds of men who
have prostate cancer surgery experience urinary incontinence afterward,
but new research suggests that behavioral therapy can help lessen bladder
control problems for a significant number of them."
After eight weeks of behavioral therapy -- including fluid management, pelvic exercises and bladder control techniques -- the researchers found a 55 percent reduction in incontinence episodes.
It's not a perfect treatment, and it does require work, but it also provides a significant improvement in quality of life.
Friday, January 7, 2011
Women's tears send "no sex" message to men: study
The findings, in a study by the Weizmann Institute of Science and Wolfson Hospital near Tel Aviv on the role tears play in non-verbal communication, suggest that a chemical in women's tears lowers men's testosterone levels.
Researchers had expected the tears would boost the men's sense of empathy. Instead, their heart and respiratory rates, salivary testosterone and a brain scan all pointed to a reduction of sexual arousal.
The chemo-signal in women's tears, he said, was one way of saying "no, I am not interested."
Communication is key to survival. Humans, like all mammals, use smell in their communication. It is very efficient if you have a chemical signal which transmits what you want -- or clearly don't want -- in a sexual situation.
Thursday, January 6, 2011
Exercise May Improve Odds Against Prostate Cancer Death (HealthDay)
(HealthDay): "HealthDay - WEDNESDAY, Jan. 5 (HealthDay News) -- Prostate cancer patients
who routinely engage in modest amounts of vigorous physical exercise
appear to lower their risk of dying from their disease, new research
suggests."
Three hours a week or more of vigorous biking, tennis, jogging or swimming seems to improve the prognosis among such patients, the research team found. But they added that even moderate physical activity appears to lower the overall risk of dying from any cause.
Focusing specifically on walking (the most popular activity, accounting for more than one-third of total MET-hours per week among the patients), Kenfield and her team found that seven or more hours per week of walking conferred a "significant benefit" relative to walking less than 20 minutes per week.
The authors further found that pace mattered, as those men who walked at a "normal" pace had a 37 percent lower risk of dying from any cause than men who walked at an "easy" pace. Those who walked at a "brisk" or "very brisk" pace fared even better, experiencing a 48 percent drop in their risk for death.
Tuesday, December 28, 2010
Cataracts linked to prostate cancer treatment
After accounting for other risk factors for cataracts, they found that men treated with the hormone drugs had, on average, a 9 percent increased risk of developing a cataract compared to those not treated with ADT (androgen deprivation therapy). The risk rose by around 26 percent for the far smaller proportion of men who had their testicles removed.
The increased risk is relatively small but because so many men use ADT, it is estimated that about 5 percent of cataract cases in men with prostate cancer might be blamed on the therapy.
With ADT so commonly used as part of a patient's treatment for prostate cancer, it is important to have a complete understanding of the negative consequences of therapy.
Patients should be monitored carefully while on ADT for new diagnoses of diabetes, and potentially cataract.
Thursday, December 16, 2010
PSA test can be made more accurate with gene markers
Screening using PSA blood tests is controversial because cancer is missed in some men while others get false positive results.
An Icelandic-led team said they had discovered several DNA variations that affect background blood levels of PSA.
In the future, testing for these gene variations may be able to create much more accurate individual PSA thresholds.
"By using these markers ... we believe we have made the PSA test both more specific and more sensitive," Kari Stefansson said. However, Kate Holmes, research manager at Britain's Prostate Cancer Charity, said more research on a large number of men was needed to investigate the accuracy of the new approach.
Monday, December 13, 2010
Sperm-Producing Cells May One Day Cure Diabetes
(HealthDay): "HealthDay - SUNDAY, Dec. 12 (HealthDay News) -- Researchers have been able to
prod human cells that normally produce sperm to make insulin instead and,
after transplanting them, the cells briefly cured mice with type 1
diabetes."
Once the cells were coaxed into becoming insulin-producing cells, the researchers transplanted them into the mice.
The goal is to coax these cells into making enough insulin to cure diabetes. These cells don't secrete enough insulin to cure diabetes in humans yet.
A benefit of the technique developed by Gallicano and his team is that the cells are coming from the same person they'll be transplanted in, so the body won't see the cells as foreign.
The only side effect of concern, said Gallicano, is a certain type of tumor called a teratoma. But, he said, it appears with these cells it would take significantly more transplanted cells than would likely be needed before such a tumor might potentially be created.
Saturday, December 11, 2010
Semen Quality Not Affected by Vitamin D Levels
Researchers were surprised to find that the sperm-filled fluid of men with low blood levels of vitamin D was of no less quality than the semen from men with normal or high vitamin D levels.
Still, a relationship between vitamin D and semen quality can't yet be ruled out. Ramlau-Hansen pointed to some limitations of the study, including the small number of subjects who were actually vitamin-D deficient
Until further studies strengthen and refine the findings, Ramlau-Hansen can only say that more vitamin D "may not be important" for semen quality in men with vitamin levels already in the optimal range.